Amendment of regulation 299 (medical sales representatives)U.K.
This section has no associated Explanatory Memorandum
217. In regulation 299(3), [F1for “marketing authorisation,” substitute “UK marketing authorisation, EU marketing authorisation”.]
Textual Amendments
F1Words in reg. 217 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 176
Commencement Information
I1Reg. 217 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1